Protease levels are significantly altered in pediatric burn wounds

Stacey C Schutte1, Alexander Evdokiou2, Latha Satish3

  • 1Department of Research, Shriners Hospitals for Children-Cincinnati, 3229 Burnet Avenue, Cincinnati, OH 45229, USA; Department of Biomedical Engineering, University of Cincinnati, 2901 Woodside Drive, Cincinnati, OH 45221, USA.

Insights

Pediatric burn wounds show increased collagenase and elastase activity, primarily from matrix metalloproteinases (MMPs). This suggests MMPs play a key role in early burn healing and warrant further study.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Wound Healing Research

Background:

  • Burn wounds exhibit high protease activity essential for extracellular matrix remodeling.
  • Excessive protease activity can impair wound healing, leading to fibrosis and contraction.
  • Limited research exists on the comprehensive expression of collagenases and elastases in burn wounds.

Purpose of the Study:

  • To compare gene expression and activity of collagenases and elastases in pediatric burn wounds versus normal skin.
  • To identify specific proteases upregulated or downregulated in burn wound eschar.
  • To investigate the role of matrix metalloproteinases (MMPs) in early burn wound healing.

Main Methods:

  • RNA sequencing and qRT-PCR for gene expression analysis.
  • Activity assays to measure collagenase and elastase function.
  • Western blotting and substrate zymography for protein-level evaluation.
  • Analysis of pediatric burn eschar and normal skin tissue samples.

Main Results:

  • Significantly increased collagenase and elastase activity in burn wounds compared to normal skin.
  • Upregulation of four elastases and three collagenases in burn tissues.
  • Most studied matrix metalloproteinases (MMPs) were significantly upregulated.
  • Cathepsin V was the only significantly downregulated protease; serine proteases showed no significant alteration.

Conclusions:

  • Matrix metalloproteinases (MMPs) are the predominant elevated proteases in pediatric burn wounds within the first 3-7 days post-injury.
  • Findings highlight the significant role of MMPs in the early stages of burn wound healing.
  • Further research is recommended to explore the therapeutic potential of targeting MMPs in burn care.

Related Concept Videos

Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
3.8K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.1K
Inflammatory Response II: Inflammatory Exudate and Tissue Repair01:24

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
6.9K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
123